NHS-dPEG®₄-biotinidase resistant biotin

$150.00$1,200.00

Clear

PRODUCT IS SOLD STRICTLY FOR INTERNAL LABORATORY AND RESEARCH PURPOSES ONLY AND HAS NOT BEEN REVIEWED BY THE FDA. PRODUCT IS NOT FOR RESALE AND CANNOT BE INCORPORATED INTO COMMERCIAL GOODS FOR ANY USE OR USED IN THE DEVELOPMENT OF COMMERCIAL PRODUCTS OR IN THE PERFORMANCE OF COMMERCIAL SERVICES UNLESS UNDER A SEPARATE LICENSING, SUPPLY, OR DISTRIBUTOR AGREEMENT WITH QUANTA BIODESIGN, LTD. For information pertaining to the commercial use of our products, please click here to contact us.

Email Sales@QuantaBioDesign.com for Bulk Pricing and Custom Syntheses

TFP_Esters_Art2

NHS-dPEG®4-biotinidase-resistant biotin is a water-soluble biotinylation reagent that has been modified to resist hydrolysis by biotinidase (EC 3.5.1.12). This product combines Biotinoyl-2-aminobutyric acid with the N-hydroxysuccinimidyl (NHS) ester of a single molecular weight, discrete polyethylene glycol (dPEG®) linker. NHS-dPEG®4-biotinidase-resistant biotin retains biotin’s typical high affinity for avidin and streptavidin. However, the modified biotin prevents recycling by biotinidase. This product is useful in applications such as ELISAs of tissue samples and antibody pretargeting, where endogenous biotinidase potentially can recycle biotin.

Development and Uses of NHS-dPEG®4-biotinidase-resistant biotin

For an explanation of biotinylation with dPEG® products, please click here.

Biotinidase is an amidohydrolase that breaks the covalent bond between biotin and amino acids such as lysine (i.e., biocytin). In vivo, biotinidase recycles biotin. Although necessary for healthy bodily function, biotinidase potentially creates problems when biotinylated proteins are used in serological assays, since endogenous biotinidase removes the biotin from these proteins.

Dr. D. Scott Wilbur and colleagues at the University of Washington in Seattle developed biotinidase-resistant biotin in 2006. Development of biotinidase-resistant biotin arose from a need for biotinylation reagents that could facilitate in vivo antibody pretargeting. However, to improve the product’s water solubility, Quanta BioDesign conjugated a short amino-dPEG®4-propionic acid linker to biotinidase-resistant biotin. For practical use in bioconjugation, the NHS ester then was synthesized. Indeed, NHS-dPEG®4-biotinidase-resistant biotin is the biotinidase-resistant version of our highly popular NHS-dPEG®4-biotin product.

Like our other dPEG® biotinylation products, NHS-dPEG®4-biotinidase-resistant biotin will not cause aggregation and precipitation of biomolecules to which it is conjugated. Moreover, the dPEG® spacer in this product reduces non-specific binding. Aggregation, precipitation, and non-specific binding are common problems with the widely used LC-biotin reagents.

NHS-dPEG®4-biotinidase-resistant biotin resists amide hydrolysis because of the non-natural amino acid to which it is conjugated. This product potentially is beneficial for applications that use serological fluids containing endogenous biotinidase. Useful roles for NHS-dPEG®4-biotinidase-resistant biotin include the following:

  • therapeutic applications such as antibody pretargeting with biotin-streptavidin systems;
  • supramolecular constructs (g., nanoparticles) used in vivo that depend on biotin-(strept)avidin affinity to maintain structural integrity; and,
  • ELISAs of serological fluids and tissue samples using biotin-(strept)avidin affinity.

Products Similar to NHS-dPEG®4-biotinidase-resistant biotin

In addition to this NHS ester-activated construct, Quanta BioDesign offers two versions of this product functionalized with 2,3,5,6-tetrafluorophenyl (TFP) esters. TFP esters possess greater hydrolytic stability and amine reactivity compared to NHS esters.

Commercial Scale Production Is Available for NHS-dPEG®4-biotinidase-resistant biotin

If you need bulk product in a larger package size than our standard sizes, please contact us for a quote. Our commercial capabilities permit us to manufacture this product at any scale that you need.

Act Now

Hydrophobic LC-biotin reagents are known to be problematic in bioconjugation work. Moreover, when working with serological fluids and tissue samples, endogenous biotinidase potentially creates problems in analyzing test results.

Stop using inferior biotinylation reagents! You can do better. Quanta BioDesign offers better biotinylation tools. Our dPEG®-based biotinylation reagents offer water solubility, improved hydrodynamic volume, no background noise (which means better signal), and no protein precipitation caused by aggregation. Why would you not use something better?

For better biotinylation, click the “Add to Cart” button now. You will not regret it.

Additional information

Weight .5 oz
Dimensions .75 × .75 × 2 in